American Conference Institute’s popular "FDA Boot Camp" returns to the University of Chicago’s Gleacher Center in downtown Chicago on September 25-26. ACI expects a sell-out of this conference and recommends early registration.
The conference is designed to give patent lawyers, product liability lawyers, and life sciences investment and securities experts a strong working knowledge of core FDA regulatory competencies. It features FDA regulatory and patent law experts from pharmaceutical companies and outside law firms.
Presentations on the agenda include:
- The Basics: Understanding and Working with the FDA–Jurisdiction, Functions, Organization, and Operations
- The Nature of the Approval Process
- Patent and IP Overview for Drugs and Biologics: Hatch-Waxman, Trade Dress, and More (I’ll be on this panel, speaking about Hatch-Waxman)
- Drugs and Biologics: Labeling
- Non-patent Exclusivity
- Bioequivalence: What Patent Lawyers Need to Know
- Follow-on Biologics
- Medical Devices: Classification and the Essentials of the Device Premarket Review Process
The co-chairs of the conference are Coleen Klasmeier of Sidley Austin LLP and Erika Lietzan of Covington & Burling LLP. Additional details and registration information are available at the ACI FDA Boot Camp web site.
Orange Book Blog is a media partner of this conference.

Leave a comment